SCN1A and encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy: Consistent with the effects of the SCN1A gene mutation observed in mouse models of Dravet syndrome, this finding confirms impaired gamma oscillatory activity as a relevant marker of the disease.